Predicting the recurrence risk of liver metastasis from colorectal cancer: a study based on preoperative CT intratumoral and peritumoral radiomics features

基于术前CT肿瘤内及肿瘤周围放射组学特征预测结直肠癌肝转移复发风险的研究

阅读:1

Abstract

OBJECTIVE: This study aims to explore the value of predicting the recurrence risk of colorectal cancer liver metastasis (CRLM) based on preoperative CT intratumoral and peritumoral radiomics features. METHODS: This study utilized retrospectively collected preoperative CT data of 201 CRLM patients, comprising 145 cases from the hospital one and 56 cases from an external hospital two. Liver metastases were precisely segmented via manual annotation. Subsequently, the intratumoral region of interest (ROI(Intra)) was isotropically dilated to radii of 2 mm, 4 mm, and 6 mm, resulting in peri-tumoral ROIs (ROI(Peri2mm), ROI(Peri4mm) and ROI(Peri6mm)). We established the prediction models based on support vector machine (SVM), random forest (RF), and multilayer perceptron (MLP) algorithms. The area under the subject operating characteristic curve (AUC) was used to evaluate the predictive performance. RESULTS: Compared with SVM and RF, MLP demonstrated superior predictive performance for estimating the recurrence risk of CRLM patients. The best radiomics signatures for predicting the recurrence risk of CRLM were ROI(Intra+Peri4mm) model, and the AUCs of the ROI(Intra) model, ROI(Intra+Peri2mm) model, ROI(Intra+Peri4mm) model, and ROI(Intra+Peri6mm) model constructed by MLP are 0.758 (95% confidence interval (CI), 0.621 - 0.865), 0.815 (95% CI, 0.684 - 0.908), 0.855 (95% CI, 0.731 - 0.936), and 0.825 (95% CI, 0.696 - 0.915), respectively, in the external test set. CONCLUSION: Preoperative CT-based radiomics features extracted from intra-tumoral (ROI(Intra)) and peritumoral (ROI(Intra+Peri2mm), ROI(Intra+Peri4mm), and ROI(Intra+Peri6mm)) regions can effectively predict recurrence risk in CRLM patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。